Pan Wu, Cai Shen-Yang, Luo Hai-Long, Ouyang Shu-Rui, Zhang Wen-Duo, Wei Zai-Rong, Wang Da-Li
Department of Plastic & Vascular Surgery, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou, People's Republic of China.
Department of Hepatopancreatobiliary Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Ther Clin Risk Manag. 2016 Apr 15;12:607-12. doi: 10.2147/TCRM.S100266. eCollection 2016.
Chylous ascites is the pathologic leakage of triglycerides-rich lymphatic fluid into the peritoneal cavity. Chylous ascites is a rare complication in abdominal surgery. This study aimed to find a relatively better method for nutrition support in the treatment of chylous ascites after abdominal surgery.
This study was a retrospective study. This study retrospectively reviewed patients who underwent abdominal surgery and developed chylous ascites, from the year 2010 to 2014, at the West China Hospital of Sichuan University and the Affiliated Hospital of Zunyi Medical College. Fifty-eight patients who developed chylous ascites after abdominal surgery were included in the study. The clinical effect of somatostatin was evaluated. The differences in the curative efficacy among a daily diet, a low-fat diet supplemented with medium-chain triglyceride (MCT), and total parenteral nutrition (TPN) were also analyzed in this study.
Complete clinical success was reached earlier in patients treated with somatostatin (P<0.001). The tube removal time, the time to resumption of an oral diet, and the length of hospital stay after chylous leakage were significantly different between patients treated with and without somatostatin. The curative efficacies of the enteral nutrition (EN) + MCT plan and the TPN plan were quite similar, with no significant difference, however, were significantly different from the MCT regime, which was the worst. However, using the EN + MCT plan was more cost-effective (P=0.038).
In treating chylous ascites, EN + MCT instead of TPN was the best nutrition support. Moreover, somatostatin or its analog octreotide should be used immediately. The treatment with somatostatin in combination with EN + MCT is recommended in the conservative treatment of postoperative chylous ascites.
乳糜性腹水是富含甘油三酯的淋巴液病理性漏入腹腔。乳糜性腹水是腹部手术中一种罕见的并发症。本研究旨在寻找一种相对更好的营养支持方法用于腹部手术后乳糜性腹水的治疗。
本研究为回顾性研究。回顾性分析了2010年至2014年在四川大学华西医院和遵义医学院附属医院接受腹部手术并发生乳糜性腹水的患者。纳入58例腹部手术后发生乳糜性腹水的患者。评估了生长抑素的临床效果。本研究还分析了日常饮食、补充中链甘油三酯(MCT)的低脂饮食和全胃肠外营养(TPN)之间疗效的差异。
接受生长抑素治疗的患者临床完全缓解出现得更早(P<0.001)。生长抑素治疗组与未治疗组患者在拔管时间、恢复经口饮食时间以及乳糜漏后住院时间方面存在显著差异。肠内营养(EN)+MCT方案和TPN方案的疗效相当,无显著差异,但与最差的MCT方案显著不同。然而,使用EN+MCT方案更具成本效益(P=0.038)。
在治疗乳糜性腹水中,EN+MCT而非TPN是最佳的营养支持。此外,应立即使用生长抑素或其类似物奥曲肽。建议在术后乳糜性腹水的保守治疗中采用生长抑素联合EN+MCT进行治疗。